Christoph Lengauer, Chief Scientific Officer at Blueprint Medicines Corp (BPMC), sold 37,706 shares at $20.30 ($759K) on 2016-04-11, disclosed to the SEC on 2016-04-13.
Open-market sale of $759k BPMC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.30 | 8,537 | $173K | 22.8% |
| 2 | $20.30 | 8,537 | $173K | 22.8% |
| 3 | $20.01 | 10,316 | $206K | 27.2% |
| 4 | $20.01 | 10,316 | $206K | 27.2% |
| Total | $20.14 avg | 37,706 | $759K | 100% |
| Filing → |
| BPMC | SELL | 2015-11-04 | $1.8M | — | Filing → |